RI
CAPR icon

RTW Investments’s Capricor Therapeutics CAPR Stock Holding History

RTW Investments’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.02M Hold
250,000
– – 0.05% 76
2026
Q1 		$7.6M Hold
250,000
– – 0.08% 72
2025
Q4 		$7.21M Buy
+250,000
New +$3.26M 0.07% 76

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RTW Investments's CAPR Position: Q2 2026 in Review

RTW Investments held its Capricor Therapeutics (CAPR) position steady in Q2 2026 at 250,000 shares worth $6.02M. The position accounts for 0.05% of the portfolio, ranked #76.

RTW Investments first reported a position in CAPR in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.6M in Q1 2026. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • RTW Investments held 250,000 shares of Capricor Therapeutics worth $6.02M as of Q2 2026.
  • RTW Investments left its Capricor Therapeutics share count unchanged in Q2 2026.
  • Capricor Therapeutics made up 0.05% of RTW Investments's portfolio in Q2 2026, its #76 holding.
  • RTW Investments first reported a position in Capricor Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • RTW Investments's Capricor Therapeutics position peaked at $7.6M in Q1 2026.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.